Citation: J. Seghatchian, New developments in blood components: focus on improved safety of blood components through process modification, TRANSF AP S, 24(3), 2001, pp. 231-232
Citation: N. Beckman et J. Seghatchian, Monitoring universal leucodepletion performance: the current issues withincomponents production and testing, TRANSF AP S, 24(3), 2001, pp. 233-236
Citation: P. Krailadsiri et J. Seghatchian, Effect of processing and storage on platelet activation, cellular injury and microvesiculation, TRANSF AP S, 24(3), 2001, pp. 237-238
Citation: P. Krailadsiri et J. Seghatchian, Residual red cell and platelet content in WBC-reduced plasma measured by anovel flow cytometric method, TRANSF AP S, 24(3), 2001, pp. 279-286
Citation: J. Seghatchian et P. Krailadsiri, Changes in patterns of Bradykinin generation during leucocyte filtration of platelet concentrates, TRANSF AP S, 24(3), 2001, pp. 291-292
Citation: J. Seghatchian et al., Studies on the improvement of leucodepletion performance of the Haemonetics MCS plus for production of leucodepleted platelet concentrate, PLATELETS, 12(5), 2001, pp. 298-301
Citation: J. Seghatchian et al., A case of leucodepletion failure in Cobe spectra plateletpheresis: furtherstudies on the identification of the potential cause, PLATELETS, 12(5), 2001, pp. 302-308
Authors:
Krailadsiri, P
Seghatchian, J
Williamson, LM
Citation: P. Krailadsiri et al., Platelet storage lesion of WBG-reduced, pooled, buffy coat-derived platelet concentrates prepared in three in-process filter/storage bag combinations, TRANSFUSION, 41(2), 2001, pp. 243-250
Citation: J. Seghatchian et al., Counting of residual WBCs in WBC-reduced blood components: a multicenter evaluation of a microvolume fluorimeter by the United Kingdom National BloodService, TRANSFUSION, 41(1), 2001, pp. 93-101
Citation: J. Seghatchian et al., Statistical process monitoring of WBC-reduced blood components assessed bytwo types of software, TRANSFUSION, 41(1), 2001, pp. 102-105
Citation: N. Beckman et J. Seghatchian, Leucodepletion process performance variation: is it dependent on the batchof filters, the processing centre or the counting technology?, TRANSFUS SC, 23(2), 2000, pp. 113-118
Citation: J. Seghatchian et al., The role of in process qualification in quality improvement of the haemonetics MCS plus leucodepleted platelet concentrate, TRANSFUS SC, 22(3), 2000, pp. 165-169
Citation: N. Beckman et J. Seghatchian, UK strategy for process qualification/validation: from concept to practical implementation, TRANSFUS SC, 22(3), 2000, pp. 203-206
Authors:
Murphy, MF
Seghatchian, J
Krailadsiri, P
Howell, C
Verjee, S
Citation: Mf. Murphy et al., Evaluation of Cobe Trima for the collection of blood components with particular reference to the in vitro characteristics of the red cell and platelet concentrates and the clinical responses to transfusion, TRANSFUS SC, 22(1-2), 2000, pp. 39-43
Authors:
Beard, MJ
Seghatchian, J
Cardigan, R
Bennett, J
Smith, KS
Williamson, L
Citation: Mj. Beard et al., Leucofiltration of sickle cell trait blood "the blocker": NBS London & SE experience, TRANSFUS SC, 22(1-2), 2000, pp. 71-73
Authors:
Hornsey, V
Drummond, O
MacGregor, I
Bethel, H
Krailadsiri, P
Smith, K
Seghatchian, J
Prowse, C
Citation: V. Hornsey et al., Leucofiltration, retention/generation of soluble prion and annexin V and storage of blood components, TRANSFUS SC, 22(1-2), 2000, pp. 75-76
Authors:
Seghatchian, J
Krailadsiri, P
Chandegra, B
Beard, M
Beckman, N
Bissett, L
Morris, B
Booker, W
Citation: J. Seghatchian et al., National evaluation of IMAGN 2000 for quality monitoring of leucodepleted red cell and platelet concentrates: comparison with flow and Nageotte, TRANSFUS SC, 22(1-2), 2000, pp. 77-79